𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evidence for mutational cis-acting factors affecting mutagenesis in the ornithine transcarbamylase gene

✍ Scribed by Luísa Azevedo; Consuelo Climent; Laura Vilarinho; F. Calafell; António Amorim

Book ID
102264978
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
86 KB
Volume
24
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis

Ornithine transcarbamylase (OTC; EC 2.1.3.3) is an urea cycle enzyme coded by a gene located at Xp21.1. The genetic deficiency is caused by a wide spectrum of pathological mutations, most of them occurring de novo. Using two (CA)n flanking markers of the OTC gene (DXS997 and DXS1068), we have defined the haplotypic background underlying 37 different mutational events and compared the results with a random sample of control chromosomes (N=141) from Iberia Peninsula. The allelic distribution of the (CA)n markers revealed significant differences between affected and non-affected chromosomes. One particular haplotypic combination can be considered as a risk factor for carrying OTC mutations, with a relative risk of 13.3 (95% confidence interval 2.89-61.5, p=1.5 x 10(-5)). Since most of pathogenic OTC mutations are short-lived or de novo, these findings strongly support the hypothesis that a specific haplotypic background confers a higher risk for mutation occurrence at this locus.

📜 SIMILAR VOLUMES

Identification of seven novel missense m
Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency
✍ Consuelo Climent; Vicente Rubio 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB 👁 1 views

Ornithine transcarbamylase (OTC) deficiency, a X-linked disorder, is the most frequent inborn error of the urea cycle. Point mutations and small deletions/insertions in the OTC gene are responsible for the majority of the cases and have a "private"character with little recurrence. We report on eleve

Identification of a cytogenetic deletion
Identification of a cytogenetic deletion and of four novel mutations (Q69X, I172F, G188V, G197R) affecting the gene for ornithine transcarbamylase (OTC) in Spanish patients with OTC deficiency
✍ Consuelo Climent; Miguel Ángel García-Pérez; Pablo Sanjurjo; José-Ignacio Ruiz-S 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 16 KB 👁 3 views

A deletion of at least 11.5 cM in the paternal X chromosome mapping between microsatellites DXS989 and DXS1003 and encompassing the genes for ornithine transcarbamylase (OTC), retinitis pigmentosa GTPase regulator (RPGR) and dystrophin, was associated with the loss of band Xp21 in a female patient w

Prenatal monitoring in a family at high
Prenatal monitoring in a family at high risk for ornithine transcarbamylase (OTC) deficiency: A new mutation of an A-to-C transversion in position +4 of intron 1 of the OTC gene that is likely to abolish enzyme activity
✍ Hoshide, Ryuuji; Matsuura, Toshinobu; Sagara, Yusuke; Kubo, Takahiko; Shimadzu, 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 562 KB

DNA analysis of a male propositus with ornithine transcarbamylase (OTC) deficiency documented an A-to-C substitution in position +4 of intron 1. No other abnormalities were observed in the OTC gene, or at 563 bp upstream of the 5' site, which included a promoter region, or at 383 bp downstream of th